Logo image of SMED

SHARPS COMPLIANCE CORP (SMED) Stock Analyst Earnings Estimates

NASDAQ:SMED - Nasdaq - US8200171010 - Common Stock - Currency: USD

8.75  +0.01 (+0.11%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
SMED revenue by date.SMED revenue by date.
44.31M
10.39%
51.15M
15.44%
76.424M
49.41%
66.742M
-12.67%
68.714M
2.95%
77.367M
12.59%
81.746M
5.66%
88.101M
7.77%
EBITDA
YoY % growth
SMED ebitda by date.SMED ebitda by date.
2.11M
115.31%
2.52M
19.43%
14.291M
467.10%
2.412M
-83.12%
4.964M
105.78%
8.466M
70.55%
15.618M
84.47%
29.387M
88.16%
EBIT
YoY % growth
SMED ebit by date.SMED ebit by date.
450K
177.59%
910K
102.22%
12.302M
1,251.87%
-153K
-101.24%
2.448M
1,700.00%
7.038M
187.50%
17.25M
145.10%
43.125M
150.00%
Operating Margin
SMED operating margin by date.SMED operating margin by date.
1.02%1.78%16.10%-0.23%3.56%9.10%21.10%48.95%
EPS
YoY % growth
SMED eps by date.SMED eps by date.
0.01
120.00%
0.13
1,200.00%
0.62
376.92%
0.02
-96.71%
0.09
325.00%
0.27
205.88%
0.65
145.10%
1.63
150.00%

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24
EPS
Q2Q % growth
0.04
-76.00%
-0.02
49.00%
0.00
-100.00%
0.08
916.00%
0.10
150.00%
0.02
200.00%
0.06
Revenue
Q2Q % growth
18.666M
-0.36%
16.014M
15.08%
15.81M
-51.79%
19.38M
10.25%
21.318M
14.21%
18.972M
18.47%
18.768M
18.71%
EBITDA
Q2Q % growth
1.734M
-56.45%
102K
108.97%
714K
183.33%
N/AN/AN/AN/A
EBIT
Q2Q % growth
1.122M
-43.70%
-510K
70.33%
102K
111.16%
N/AN/AN/AN/A

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth
-0.01
-102.50%
0.02-0.03-149.02%
Q2 2022
Q2Q % growth
0.07 0.000.071,369.54%
Q1 2022
Q2Q % growth
-0.04
-100.00%
0.04-0.08-204.58%
Q4 2021
Q2Q % growth
0.17
30.77%
0.070.10145.82%
Q3 2021
Q2Q % growth
0.40
500.00%
-0.030.431,608.30%
Q2 2021
Q2Q % growth
0.07
16.67%
0.20-0.13-65.69%
Q1 2021
Q2Q % growth
-0.02
-150.00%
0.14-0.16-114.76%
Q4 2020
Q2Q % growth
0.13
333.33%
0.070.0688.82%
Q3 2020
Q2Q % growth
-0.10
-42.86%
0.04-0.14-330.68%
Q2 2020
Q2Q % growth
0.06
20.00%
0.010.05684.31%
Q1 2020
Q2Q % growth
0.04 -0.050.09188.46%
Q4 2019
Q2Q % growth
0.03 0.030.0010.28%
Q3 2019
Q2Q % growth
-0.07 0.01-0.08-786.27%
Q2 2019
Q2Q % growth
0.05 0.010.04634.93%
Q1 2019
Q2Q % growth
0.00 -0.010.01100.00%
SMED Yearly EPS VS EstimatesSMED Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth
17.579M
-36.15%
16.626M953K5.73%
Q2 2022
Q2Q % growth
32.793M
92.79%
15.429M17.364M112.54%
Q1 2022
Q2Q % growth
13.915M
5.82%
16.882M-2.967M-17.57%
Q4 2021
Q2Q % growth
18.734M
49.04%
18.352M381.752K2.08%
Q3 2021
Q2Q % growth
27.53M
164.46%
13.657M13.873M101.59%
Q2 2021
Q2Q % growth
17.01M
16.75%
24.015M-7.005M-29.17%
Q1 2021
Q2Q % growth
13.15M
-3.31%
22.075M-8.925M-40.43%
Q4 2020
Q2Q % growth
12.57M
3.29%
16.453M-3.883M-23.60%
Q3 2020
Q2Q % growth
10.41M
10.16%
15.284M-4.874M-31.89%
Q2 2020
Q2Q % growth
14.57M
17.59%
13.003M1.567M12.05%
Q1 2020
Q2Q % growth
13.6M
32.17%
10.849M2.751M25.35%
Q4 2019
Q2Q % growth
12.17M 12.35M-180.16K-1.46%
Q3 2019
Q2Q % growth
9.45M 11.571M-2.121M-18.33%
Q2 2019
Q2Q % growth
12.39M 10.988M1.402M12.76%
Q1 2019
Q2Q % growth
10.29M 10.29M2400.00%
SMED Yearly Revenue VS EstimatesSMED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A